UnitedHealth Group Incorporated
355.26-12.58 (-3.42%)
Oct 29, 4:00:02 PM EDT · NYSE · UNH · USD
Report date
≈ Jan 15, 2026 (in 77 days)EPS
6.77 (5.03 ~ 7.89)Revenue
113.92B (107.80B ~ 117.11B)Key Stats
Market Cap
321.81BP/E (TTM)
18.52Basic EPS (TTM)
19.18Dividend Yield
0.02%Recent Filings
10-Q
8-K
8-K
Reaffirms 2025 EPS outlook
UnitedHealth Group is reaffirming its adjusted 2025 earnings per share outlook during investor meetings from September 8 to 10, 2025, as previously shared on July 29. This guidance accounts for the August 2025 Amedisys acquisition, expected to dilute earnings modestly from financing and integration costs. Yet risks like regulatory changes and integration hurdles could sway results.
8-K
Board forms risk oversight committee
UnitedHealth Group announced Board updates on August 20, 2025, forming a new Public Responsibility Committee to oversee financial, regulatory, and reputational risks, including underwriting, mergers, and pricing. F. William McNabb steps in as lead independent director, leveraging his Vanguard CEO background, while Michele Hooper chairs the new committee. This bolsters governance amid operational challenges. Yet risks persist in coordination across committees.
10-Q
Q2 FY2025 results
UnitedHealth Group's Q2 revenues climbed 13% year-over-year to $111.6B, fueled by 17% growth at UnitedHealthcare from Medicare Advantage and Medicaid expansions, while Optum Rx surged 19% on higher script volumes; yet operating earnings dipped 35% to $5.2B as medical costs ballooned 20% to $78.6B, pushing the medical care ratio to 89.4% amid elevated trends and Medicare funding shortfalls. Diluted EPS fell to $3.74 from $4.54, aligning with 914 million shares, though YTD EPS of $10.61 reflects a strong rebound from last year's cyberattack drag. Cash from operations hit $12.6B YTD, bolstering $28.6B in cash equivalents against $79.2B total debt, including fresh $3.0B notes issued in June. Pending $4B acquisitions signal expansion, but regulatory pressures on Medicare rates loom large.
IPO
Employees
Sector
Industry
CI
The Cigna Group
299.12-9.29
CNC
Centene Corporation
37.34+4.15
CVS
CVS Health Corporation
80.60-1.60
EHTH
eHealth, Inc.
5.46-0.19
ELV
Elevance Health, Inc.
336.36-3.04
HUM
Humana Inc.
292.67-2.13
MCK
McKesson Corporation
807.63+3.04
MOH
Molina Healthcare Inc
160.28-2.56
NEUE
NeueHealth, Inc.
6.75+0.00
UNM
Unum Group
74.86+0.18